Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07219355 · ClinicalTrials.gov registry record · NA

Virtual Reality Lethal Means Safety Training

A NA study of Suicide, Attempted and Suicide Prevention, sponsored by The University of Texas at Arlington.

Recruiting
Registry status
NA
Development phase
36
Enrollment target
1
Study location

NCT07219355: Recruiting NA study of Suicide, Attempted and Suicide Prevention, sponsored by The University of Texas at Arlington.

NCT07219355 is a NA study of Suicide, Attempted and Suicide Prevention that is actively recruiting participants, run by The University of Texas at Arlington. The registered enrollment target is 36 participants, below the 378-participant average among 36 other Suicide, Attempted trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07219355, a NA study of Suicide, Attempted and Suicide Prevention, is actively recruiting participants, sponsored by The University of Texas at Arlington.

RECRUITING
Registry status
NA
Development phase
36 participants
Enrollment target
1
Study location

Study Summary

The goal of this randomized clinical trial is to determine whether a virtual reality (VR) training program can help healthcare providers improve their skills in discussing suicide prevention and safe storage of firearms and medications with Veterans. The study will test whether VR training increases providers' self-efficacy, confidence, and comfort in conducting lethal means safety counseling, and whether it improves their intention to use these counseling practices in their clinical work. Researchers will compare healthcare providers who complete the VR training to those who complete a 2D video training to determine whether the VR approach is more effective. Participants will complete online surveys before and after the training and again three months later. They will be randomly assigned to one of two groups: VR training group: Participants use a VR headset to interact with a virtual Veteran patient in a simulated rural clinic and practice suicide prevention counseling skills; Video training group: Participants use the same headset to watch a \~10-minute 2D video depicting the lethal means safety counseling session. After the training, participants will also provide feedback about their experience, including how realistic and useful they found the training.

Primary Outcome

Measured by the Counseling on Access to Lethal Means (CALM) Core Scale (Sale et al., 2018) Confidence subscale ("How confident are you that …"). Items are rated on a 4-point scale and summed; higher scores indicate greater confidence (range = 5 - 20).

Interventions

  • BEHAVIORAL Virtual Reality Lethal Means Safety Training
  • BEHAVIORAL 2D Video Training

Study Locations (1)

Texas

  • University of Texas at Arlington - Arlington

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2026-02-23
Est. Completion 2026-09-30
Phase NA

What NCT07219355 shows while recruiting

NCT07219355 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 378-participant average among 36 other Suicide, Attempted trials with a reported enrollment target (90% lower).

The record links to 6 conditions, with Suicide, Attempted appearing as the primary indexed condition, and to 2 interventions - of which Virtual Reality Lethal Means Safety Training is the first listed.

NCT07219355 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT07219355 about?

NCT07219355 is a clinical study titled "Virtual Reality Lethal Means Safety Training". The goal of this randomized clinical trial is to determine whether a virtual reality (VR) training program can help healthcare providers improve their skills in discussing suicide prevention and safe storage of firearms and medications with Veterans. The study will test whether VR training increases...

What is the current status of trial NCT07219355?

This trial is currently recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2026-02-23. Estimated completion is 2026-09-30.

What conditions does trial NCT07219355 study?

This clinical trial studies the following conditions: Suicide, Attempted, Suicide Prevention, Rural Health, Veterans, Suicide, Completed.

What interventions are being tested in trial NCT07219355?

The interventions under investigation include: Virtual Reality Lethal Means Safety Training (BEHAVIORAL), 2D Video Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT07219355?

This trial is sponsored by The University of Texas at Arlington, which has 32 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07219355 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Suicide, Attempted

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07219355's enrollment target sits among peer trials

36 35th of 36 higher than 2 of 36 other Suicide, Attempted trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Suicide, Attempted trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00929006 · 36 participants · Early Phase 1

    Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism

  • NCT01891318 · 36 participants · Phase 1

    Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study

  • NCT02291848 · 36 participants · Phase 1

    Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma

  • NCT02366819 · 36 participants · Phase 4

    Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07219355, the US trial registry maintained by the National Library of Medicine. NCT07219355 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.